Antiemetics for Cancer Treatment - Global and China Top Players Market Share and Ranking 2023
According to Latest Study, the global market for Antiemetics for Cancer Treatment should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Antiemetics for Cancer Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Antiemetics for Cancer Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Highly Emetogenic Chemotherapy grew percent to account for percent of the total market sales, and Moderately Emetogenic Chemotherapy grew percent.
Emetogenic symptoms are associated with nausea and vomiting associated with cancer treatments such as chemotherapy, radiation therapy, and drug therapy. Nausea and vomiting are major side effects of cancer treatment. It is important that nausea and vomiting are controlled so patients can continue treatment and have a better quality of life. Nausea and vomiting, primarily due to, can also be induced in patients receiving chemotherapy and radiation therapy of the brain, gastrointestinal tract, or liver.
This report studies and analyses global Antiemetics for Cancer Treatment status and future trends, helps the client to determine the Antiemetics for Cancer Treatment market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Antiemetics for Cancer Treatment, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Antiemetics for Cancer Treatment market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Antiemetics for Cancer Treatment sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Antiemetics for Cancer Treatment sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Antiemetics for Cancer Treatment key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Antiemetics for Cancer Treatment key producing regions, capacity, production, and year over year growth
(6) Antiemetics for Cancer Treatment industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Heron Therapeutics, Inc
Sandoz International GmbH
Merck & Co., Inc
Eisai Co., Ltd
Teva Pharmaceutical Industries Ltd
F. Hoffmann-La Roche Ltd
Mylan N.V
GSK plc
Mundipharma International
Baxter
Bayer AG
Cipla Inc
Sanofi
Sun Pharmaceutical Industries Ltd
Qilu Pharmaceutical Co.,Ltd
Market segment by Type, covers
Serotonin Receptor Antagonists
Neurokinin-1 Receptor Antagonist
Corticosteroids
Olanzapine
Other
Market segment by Application, can be divided into
Highly Emetogenic Chemotherapy
Moderately Emetogenic Chemotherapy
Low Emetogenic Chemotherapy
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Antiemetics for Cancer Treatment product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Antiemetics for Cancer Treatment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Antiemetics for Cancer Treatment market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Antiemetics for Cancer Treatment, percent & CAGR, 2018-2029
Chapter 5: Antiemetics for Cancer Treatment industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Antiemetics for Cancer Treatment Definition
1.2 Global Antiemetics for Cancer Treatment Market Size and Forecast
1.2.1 By Consumption Value, Global Antiemetics for Cancer Treatment Market Size，2018-2029
1.2.2 By Sales Quantity, Global Antiemetics for Cancer Treatment Market Size，2018-2029
1.2.3 Global Antiemetics for Cancer Treatment Average Selling Price (ASP)，2018-2029
1.3 China Antiemetics for Cancer Treatment Market Size and Forecast
1.3.1 By Consumption Value, China Antiemetics for Cancer Treatment Market Size，2018-2029
1.3.2 By Sales Quantity, China Antiemetics for Cancer Treatment Market Size，2018-2029
1.3.3 China Antiemetics for Cancer Treatment Average Selling Price (ASP)， 2018-2029
1.4 Share of China Antiemetics for Cancer Treatment Market with Respect to the Global Market
1.4.1 By Consumption Value, China Antiemetics for Cancer Treatment Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Antiemetics for Cancer Treatment Market Share in Global, 2018-2029
1.4.3 Antiemetics for Cancer Treatment Market Size: China VS Global, 2018-2029
1.5 Antiemetics for Cancer Treatment Market Dynamics
1.5.1 Antiemetics for Cancer Treatment Market Drivers
1.5.2 Antiemetics for Cancer Treatment Market Restraints
1.5.3 Antiemetics for Cancer Treatment Industry Trends
1.5.4 Antiemetics for Cancer Treatment Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Antiemetics for Cancer Treatment, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Antiemetics for Cancer Treatment, Global Market Share by Company, 2018-2023
2.3 Antiemetics for Cancer Treatment Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Antiemetics for Cancer Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Antiemetics for Cancer Treatment Concentration Ratio
2.6 Global Antiemetics for Cancer Treatment Mergers & Acquisitions, Expansion Plans
2.7 Global Antiemetics for Cancer Treatment Manufacturers Product Type
2.8 Head Office and Antiemetics for Cancer Treatment Production Site of Key Manufacturer
2.9 Antiemetics for Cancer Treatment Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Antiemetics for Cancer Treatment, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Antiemetics for Cancer Treatment, China Market Share by Company, 2018-2023
3.3 China Antiemetics for Cancer Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Antiemetics for Cancer Treatment Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Antiemetics for Cancer Treatment Capacity by Region
4.3 Global Antiemetics for Cancer Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Antiemetics for Cancer Treatment Production by Region, 2018-2029
4.5 Global Antiemetics for Cancer Treatment Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Antiemetics for Cancer Treatment Industry Chain
5.2 Antiemetics for Cancer Treatment Upstream Analysis
5.2.1 Antiemetics for Cancer Treatment Core Raw Materials
5.2.2 Main Manufacturers of Antiemetics for Cancer Treatment Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Antiemetics for Cancer Treatment Production Mode
5.6 Antiemetics for Cancer Treatment Procurement Model
5.7 Antiemetics for Cancer Treatment Industry Sales Model and Sales Channels
5.7.1 Antiemetics for Cancer Treatment Sales Model
5.7.2 Antiemetics for Cancer Treatment Typical Distributors
6 Sights by Type
6.1 Antiemetics for Cancer Treatment Classification
6.1.1 Serotonin Receptor Antagonists
6.1.2 Neurokinin-1 Receptor Antagonist
6.1.3 Corticosteroids
6.1.4 Olanzapine
6.1.5 Other
6.2 By Type, Global Antiemetics for Cancer Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Antiemetics for Cancer Treatment Consumption Value, 2018-2029
6.4 By Type, Global Antiemetics for Cancer Treatment Sales Quantity, 2018-2029
6.5 By Type, Global Antiemetics for Cancer Treatment Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Antiemetics for Cancer Treatment Segment by Application
7.1.1 Highly Emetogenic Chemotherapy
7.1.2 Moderately Emetogenic Chemotherapy
7.1.3 Low Emetogenic Chemotherapy
7.2 By Application, Global Antiemetics for Cancer Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Antiemetics for Cancer Treatment Consumption Value, 2018-2029
7.4 By Application, Global Antiemetics for Cancer Treatment Sales Quantity, 2018-2029
7.5 By Application, Global Antiemetics for Cancer Treatment Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Antiemetics for Cancer Treatment Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Antiemetics for Cancer Treatment Consumption Value, 2018-2029
8.3 By Region, Global Antiemetics for Cancer Treatment Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Antiemetics for Cancer Treatment & Forecasts, 2018-2029
8.4.2 By Country, North America Antiemetics for Cancer Treatment Market Size Market Share
8.5 Europe
8.5.1 Europe Antiemetics for Cancer Treatment Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Antiemetics for Cancer Treatment Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Antiemetics for Cancer Treatment Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Antiemetics for Cancer Treatment Market Size Market Share
8.7 South America
8.7.1 South America Antiemetics for Cancer Treatment Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Antiemetics for Cancer Treatment Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Antiemetics for Cancer Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Antiemetics for Cancer Treatment Consumption Value, 2018-2029
9.3 By Country, Global Antiemetics for Cancer Treatment Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Antiemetics for Cancer Treatment Market Size, 2018-2029
9.4.2 By Type, U.S. Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Antiemetics for Cancer Treatment Market Size, 2018-2029
9.5.2 By Type, Europe Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Antiemetics for Cancer Treatment Market Size, 2018-2029
9.6.2 By Type, China Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Antiemetics for Cancer Treatment Market Size, 2018-2029
9.7.2 By Type, Japan Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Antiemetics for Cancer Treatment Market Size, 2018-2029
9.8.2 By Type, South Korea Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Antiemetics for Cancer Treatment Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Antiemetics for Cancer Treatment Market Size, 2018-2029
9.10.2 By Type, India Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Antiemetics for Cancer Treatment Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Heron Therapeutics, Inc
10.1.1 Heron Therapeutics, Inc Company Information, Head Office, Market Area, and Industry Position
10.1.2 Heron Therapeutics, Inc Antiemetics for Cancer Treatment Models, Specifications, and Application
10.1.3 Heron Therapeutics, Inc Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Heron Therapeutics, Inc Company Profile and Main Business
10.1.5 Heron Therapeutics, Inc Recent Developments
10.2 Sandoz International GmbH
10.2.1 Sandoz International GmbH Company Information, Head Office, Market Area, and Industry Position
10.2.2 Sandoz International GmbH Antiemetics for Cancer Treatment Models, Specifications, and Application
10.2.3 Sandoz International GmbH Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Sandoz International GmbH Company Profile and Main Business
10.2.5 Sandoz International GmbH Recent Developments
10.3 Merck & Co., Inc
10.3.1 Merck & Co., Inc Company Information, Head Office, Market Area, and Industry Position
10.3.2 Merck & Co., Inc Antiemetics for Cancer Treatment Models, Specifications, and Application
10.3.3 Merck & Co., Inc Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Merck & Co., Inc Company Profile and Main Business
10.3.5 Merck & Co., Inc Recent Developments
10.4 Eisai Co., Ltd
10.4.1 Eisai Co., Ltd Company Information, Head Office, Market Area, and Industry Position
10.4.2 Eisai Co., Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application
10.4.3 Eisai Co., Ltd Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Eisai Co., Ltd Company Profile and Main Business
10.4.5 Eisai Co., Ltd Recent Developments
10.5 Teva Pharmaceutical Industries Ltd
10.5.1 Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
10.5.2 Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application
10.5.3 Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Teva Pharmaceutical Industries Ltd Company Profile and Main Business
10.5.5 Teva Pharmaceutical Industries Ltd Recent Developments
10.6 F. Hoffmann-La Roche Ltd
10.6.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area, and Industry Position
10.6.2 F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application
10.6.3 F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 F. Hoffmann-La Roche Ltd Company Profile and Main Business
10.6.5 F. Hoffmann-La Roche Ltd Recent Developments
10.7 Mylan N.V
10.7.1 Mylan N.V Company Information, Head Office, Market Area, and Industry Position
10.7.2 Mylan N.V Antiemetics for Cancer Treatment Models, Specifications, and Application
10.7.3 Mylan N.V Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Mylan N.V Company Profile and Main Business
10.7.5 Mylan N.V Recent Developments
10.8 GSK plc
10.8.1 GSK plc Company Information, Head Office, Market Area, and Industry Position
10.8.2 GSK plc Antiemetics for Cancer Treatment Models, Specifications, and Application
10.8.3 GSK plc Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 GSK plc Company Profile and Main Business
10.8.5 GSK plc Recent Developments
10.9 Mundipharma International
10.9.1 Mundipharma International Company Information, Head Office, Market Area, and Industry Position
10.9.2 Mundipharma International Antiemetics for Cancer Treatment Models, Specifications, and Application
10.9.3 Mundipharma International Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Mundipharma International Company Profile and Main Business
10.9.5 Mundipharma International Recent Developments
10.10 Baxter
10.10.1 Baxter Company Information, Head Office, Market Area, and Industry Position
10.10.2 Baxter Antiemetics for Cancer Treatment Models, Specifications, and Application
10.10.3 Baxter Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Baxter Company Profile and Main Business
10.10.5 Baxter Recent Developments
10.11 Bayer AG
10.11.1 Bayer AG Company Information, Head Office, Market Area, and Industry Position
10.11.2 Bayer AG Antiemetics for Cancer Treatment Models, Specifications, and Application
10.11.3 Bayer AG Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Bayer AG Company Profile and Main Business
10.11.5 Bayer AG Recent Developments
10.12 Cipla Inc
10.12.1 Cipla Inc Company Information, Head Office, Market Area, and Industry Position
10.12.2 Cipla Inc Antiemetics for Cancer Treatment Models, Specifications, and Application
10.12.3 Cipla Inc Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Cipla Inc Company Profile and Main Business
10.12.5 Cipla Inc Recent Developments
10.13 Sanofi
10.13.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.13.2 Sanofi Antiemetics for Cancer Treatment Models, Specifications, and Application
10.13.3 Sanofi Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Sanofi Company Profile and Main Business
10.13.5 Sanofi Recent Developments
10.14 Sun Pharmaceutical Industries Ltd
10.14.1 Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
10.14.2 Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application
10.14.3 Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Sun Pharmaceutical Industries Ltd Company Profile and Main Business
10.14.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.15 Qilu Pharmaceutical Co.,Ltd
10.15.1 Qilu Pharmaceutical Co.,Ltd Company Information, Head Office, Market Area, and Industry Position
10.15.2 Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application
10.15.3 Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Qilu Pharmaceutical Co.,Ltd Company Profile and Main Business
10.15.5 Qilu Pharmaceutical Co.,Ltd Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Antiemetics for Cancer Treatment Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Antiemetics for Cancer Treatment Market Restraints
Table 3. Antiemetics for Cancer Treatment Market Trends
Table 4. Antiemetics for Cancer Treatment Industry Policy
Table 5. Global Antiemetics for Cancer Treatment Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Antiemetics for Cancer Treatment Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Antiemetics for Cancer Treatment Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Antiemetics for Cancer Treatment Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Antiemetics for Cancer Treatment Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Antiemetics for Cancer Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Antiemetics for Cancer Treatment Mergers & Acquisitions, Expansion Plans
Table 12. Global Antiemetics for Cancer Treatment Manufacturers Product Type
Table 13. Head Office and Antiemetics for Cancer Treatment Production Site of Key Manufacturer
Table 14. Antiemetics for Cancer Treatment Capacity of Major Manufacturers and Future Plan
Table 15. China Antiemetics for Cancer Treatment Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Antiemetics for Cancer Treatment Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Antiemetics for Cancer Treatment Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Antiemetics for Cancer Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Antiemetics for Cancer Treatment Production by Region, 2018-2023, (K Units)
Table 20. Global Antiemetics for Cancer Treatment Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Antiemetics for Cancer Treatment Upstream (Raw Materials)
Table 22. Global Antiemetics for Cancer Treatment Typical Customers
Table 23. Antiemetics for Cancer Treatment Typical Distributors
Table 24. By Type, Global Antiemetics for Cancer Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Antiemetics for Cancer Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Antiemetics for Cancer Treatment Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Antiemetics for Cancer Treatment Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Antiemetics for Cancer Treatment Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Antiemetics for Cancer Treatment Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Antiemetics for Cancer Treatment Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Antiemetics for Cancer Treatment Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Antiemetics for Cancer Treatment Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Antiemetics for Cancer Treatment Sales Quantity Market Share, 2018-2029
Table 34. Heron Therapeutics, Inc Company Information, Head Office, Market Area, and Industry Position
Table 35. Heron Therapeutics, Inc Antiemetics for Cancer Treatment Models, Specifications, and Application
Table 36. Heron Therapeutics, Inc Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Heron Therapeutics, Inc Company Profile and Main Business
Table 38. Heron Therapeutics, Inc Recent Developments
Table 39. Sandoz International GmbH Company Information, Head Office, Market Area, and Industry Position
Table 40. Sandoz International GmbH Antiemetics for Cancer Treatment Models, Specifications, and Application
Table 41. Sandoz International GmbH Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Sandoz International GmbH Company Profile and Main Business
Table 43. Sandoz International GmbH Recent Developments
Table 44. Merck & Co., Inc Company Information, Head Office, Market Area, and Industry Position
Table 45. Merck & Co., Inc Antiemetics for Cancer Treatment Models, Specifications, and Application
Table 46. Merck & Co., Inc Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Merck & Co., Inc Company Profile and Main Business
Table 48. Merck & Co., Inc Recent Developments
Table 49. Eisai Co., Ltd Company Information, Head Office, Market Area, and Industry Position
Table 50. Eisai Co., Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application
Table 51. Eisai Co., Ltd Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Eisai Co., Ltd Company Profile and Main Business
Table 53. Eisai Co., Ltd Recent Developments
Table 54. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
Table 55. Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application
Table 56. Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Teva Pharmaceutical Industries Ltd Company Profile and Main Business
Table 58. Teva Pharmaceutical Industries Ltd Recent Developments
Table 59. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area, and Industry Position
Table 60. F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application
Table 61. F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. F. Hoffmann-La Roche Ltd Company Profile and Main Business
Table 63. F. Hoffmann-La Roche Ltd Recent Developments
Table 64. Mylan N.V Company Information, Head Office, Market Area, and Industry Position
Table 65. Mylan N.V Antiemetics for Cancer Treatment Models, Specifications, and Application
Table 66. Mylan N.V Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Mylan N.V Company Profile and Main Business
Table 68. Mylan N.V Recent Developments
Table 69. GSK plc Company Information, Head Office, Market Area, and Industry Position
Table 70. GSK plc Antiemetics for Cancer Treatment Models, Specifications, and Application
Table 71. GSK plc Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. GSK plc Company Profile and Main Business
Table 73. GSK plc Recent Developments
Table 74. Mundipharma International Company Information, Head Office, Market Area, and Industry Position
Table 75. Mundipharma International Antiemetics for Cancer Treatment Models, Specifications, and Application
Table 76. Mundipharma International Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Mundipharma International Company Profile and Main Business
Table 78. Mundipharma International Recent Developments
Table 79. Baxter Company Information, Head Office, Market Area, and Industry Position
Table 80. Baxter Antiemetics for Cancer Treatment Models, Specifications, and Application
Table 81. Baxter Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Baxter Company Profile and Main Business
Table 83. Baxter Recent Developments
Table 84. Bayer AG Company Information, Head Office, Market Area, and Industry Position
Table 85. Bayer AG Antiemetics for Cancer Treatment Models, Specifications, and Application
Table 86. Bayer AG Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Bayer AG Company Profile and Main Business
Table 88. Bayer AG Recent Developments
Table 89. Cipla Inc Company Information, Head Office, Market Area, and Industry Position
Table 90. Cipla Inc Antiemetics for Cancer Treatment Models, Specifications, and Application
Table 91. Cipla Inc Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Cipla Inc Company Profile and Main Business
Table 93. Cipla Inc Recent Developments
Table 94. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 95. Sanofi Antiemetics for Cancer Treatment Models, Specifications, and Application
Table 96. Sanofi Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Sanofi Company Profile and Main Business
Table 98. Sanofi Recent Developments
Table 99. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
Table 100. Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application
Table 101. Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Sun Pharmaceutical Industries Ltd Company Profile and Main Business
Table 103. Sun Pharmaceutical Industries Ltd Recent Developments
Table 104. Qilu Pharmaceutical Co.,Ltd Company Information, Head Office, Market Area, and Industry Position
Table 105. Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Models, Specifications, and Application
Table 106. Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Qilu Pharmaceutical Co.,Ltd Company Profile and Main Business
Table 108. Qilu Pharmaceutical Co.,Ltd Recent Developments
List of Figures
Figure 1. Antiemetics for Cancer Treatment Picture
Figure 2. Global Antiemetics for Cancer Treatment Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Antiemetics for Cancer Treatment Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Antiemetics for Cancer Treatment Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Antiemetics for Cancer Treatment Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Antiemetics for Cancer Treatment Sales Quantity (K Units) & (2018-2029)
Figure 7. China Antiemetics for Cancer Treatment Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Antiemetics for Cancer Treatment Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Antiemetics for Cancer Treatment Market Share of Global, 2018-2029
Figure 10. Global Antiemetics for Cancer Treatment Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Antiemetics for Cancer Treatment Key Participants, Market Share, 2022
Figure 12. Global Antiemetics for Cancer Treatment Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Antiemetics for Cancer Treatment Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Antiemetics for Cancer Treatment Production Market Share & Forecast by Region, 2018-2029
Figure 15. Antiemetics for Cancer Treatment Industry Chain
Figure 16. Antiemetics for Cancer Treatment Procurement Model
Figure 17. Antiemetics for Cancer Treatment Sales Model
Figure 18. Antiemetics for Cancer Treatment Sales Channels, Direct Sales, and Distribution
Figure 19. Serotonin Receptor Antagonists
Figure 20. Neurokinin-1 Receptor Antagonist
Figure 21. Corticosteroids
Figure 22. Olanzapine
Figure 23. Other
Figure 24. By Type, Global Antiemetics for Cancer Treatment Consumption Value, 2018-2029, US$ Million
Figure 25. By Type, Global Antiemetics for Cancer Treatment Consumption Value Market Share, 2018-2029
Figure 26. By Type, Global Antiemetics for Cancer Treatment Sales Quantity, 2018-2029, (K Units)
Figure 27. By Type, Global Antiemetics for Cancer Treatment Sales Quantity Market Share, 2018-2029
Figure 28. By Type, Global Antiemetics for Cancer Treatment Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 29. Highly Emetogenic Chemotherapy
Figure 30. Moderately Emetogenic Chemotherapy
Figure 31. Low Emetogenic Chemotherapy
Figure 32. By Application, Global Antiemetics for Cancer Treatment Consumption Value, 2018-2029, US$ Million
Figure 33. By Application, Global Antiemetics for Cancer Treatment Consumption Value Market Share, 2018-2029
Figure 34. By Application, Global Antiemetics for Cancer Treatment Sales Quantity, 2018-2029, (K Units)
Figure 35. By Application, Global Antiemetics for Cancer Treatment Sales Quantity Market Share, 2018-2029
Figure 36. By Application, Global Antiemetics for Cancer Treatment Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 37. By Region, Global Antiemetics for Cancer Treatment Consumption Value Market Share, 2018-2029
Figure 38. By Region, Global Antiemetics for Cancer Treatment Sales Quantity Market Share, 2018-2029
Figure 39. North America Antiemetics for Cancer Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, North America Antiemetics for Cancer Treatment Consumption Value Market Share, 2022
Figure 41. Europe Antiemetics for Cancer Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, Europe Antiemetics for Cancer Treatment Consumption Value Market Share, 2022
Figure 43. Asia Pacific Antiemetics for Cancer Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country/Region, Asia Pacific Antiemetics for Cancer Treatment Consumption Value Market Share, 2022
Figure 45. South America Antiemetics for Cancer Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, South America Antiemetics for Cancer Treatment Consumption Value Market Share, 2022
Figure 47. Middle East & Africa Antiemetics for Cancer Treatment Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 48. U.S. Antiemetics for Cancer Treatment Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, U.S. Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, U.S. Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 51. Europe Antiemetics for Cancer Treatment Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, Europe Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, Europe Antiemetics for Cancer Treatment Sales Quantity Market Share, 2022 VS 2029
Figure 54. China Antiemetics f
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|